SEC Form 4 · accession 0000905148-26-002951
Atara Biotherapeutics, Inc. · ATRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian N Cherry
Director
Period of report
Jun 11, 2026
Accepted (ET)
Jun 15, 2026 · 6:51 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001604464
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 11, 2026 | A | 24,000 | $0.00 | A | 62,320 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These restricted stock units shall vest as to 1/3 of the shares on the first, second and third anniversaries of June 11, 2026, subject to the Reporting Person's continuous service.